Independent advisory for Lab Automation and High-Content Imaging

CELLIMA helps pharma, biotech, and research teams validate infrastructure and workflow decisions before procurement or rollout.

Vendor-neutral. Scientifically grounded. Based on 20+ years in pharmaceutical R&D.

No pitch. We clarify whether CELLIMA can help — and what the right next step would be.

When CELLIMA Fits

  • Before procuring imaging and lab automation infrastructure

  • When setting up or restructuring a Core Facility

  • When scaling image-based or automated workflows in Discovery

Advisory Engagements

O1

Workflow Diagnostic

Structured assessment of an existing or planned imaging or automation setup.

Written decision brief with prioritized options. 5 weeks, fixed scope.

O2

Architecture

Target architecture for imaging or automation infrastructure prior to procurement.

Reference architecture document + vendor-neutral specification. 6 weeks.

O3

Pilot Workflow

Design and supervision of a pilot workflow before full rollout.

Validated SOP + go/no-go recommendation. 8 weeks.

O4

Optimization

Targeted review of operational systems with bottlenecks or scaling issues.

Structured audit report + prioritized intervention plan. Scope on request.

Track Record

"Stefan brought both scientific depth and structural clarity into our imaging setup."
Andrea Faedo Head of Molecular and Cellular Biology Group
"Stefan's expertise in evaluating high-content imaging approaches has been instrumental in advancing our drug discovery projects."
Anke Müller-Fahrnow VP, Senior Advisor Innovation Campus Berlin

Selected organizations from consulting engagements and scientific collaborations.

BAYER

NUVISAN

AXXAM

ABBERIOR

NGNRI

BROAD

DZNE

Core Life Analytics

KOLAIDO

BAYER NUVISAN AXXAM ABBERIOR NGNRI BROAD DZNE Core Life Analytics KOLAIDO

Who You Work With

Stefan Prechtl

INDEPENDENT ADVISOR

Scientist turned consultant. 20+ years in pharmaceutical R&D at the intersection of biology, imaging, and automation. CELLIMA is built on that operational background - not on advisory theory.

Read full profile